Infinimmune

Infinimmune systematically surfaces and engineers the rare antibodies evolution has already proven in people and advances them into the clinic. The company holds the world's largest database of millions of paired heavy- and light-chain antibody sequences, sourced from a continuous pipeline of diverse healthy and diseased human donors. Using its Complete Human sequencing technology and Anthrobody library-on-B-cell platform, Infinimmune discovers fully paired, antigen-specific antibody sequences from up to 300 million B cells across 350+ targets, and applies its GLIMPSE antibody language model to optimize affinity, potency, and developability in as little as eight weeks.